Showing posts with label Lupin Pediatric Drug Revenue. Show all posts
Showing posts with label Lupin Pediatric Drug Revenue. Show all posts

Monday, January 30, 2017

The Market for Pediatric Drugs In India Is Expected to cross INR 960 Billion in the Future: Ken Research

India pediatric drugs and vaccine market has witnessed tremendous growth in the last five years largely due to high number of annual births recorded at around 25 million, launch of generic formulations of several pediatric drugs including flavored TB drugs, inclusion of several vaccines in the national immunization schedule of the country and inclining coverage of children vaccination under national immunization schedule.
In the last few years, medium to large Indian pharmaceutical companies have aggressively invested in international acquisition of companies to strengthen their foothold in developed and emerging markets globally.
generic-pediatric-drugs
India’s healthcare spending is one of the lowest in the world with the country spending only 1.2% of its GDP on health care as compared to 8.3% by the US and global mean of 5.4%, as of FY’2016. It also has the highest infant mortality rate and maternal mortality rate in the world. This has propelled the pharmaceutical industry to address the existing unmet challenges. The industry has come out with drug formulations for infants against some life threatening diseases such as tuberculosis and pneumonia which has helped to curb down the infant mortality rate in the country.
The market for pediatric drugs and vaccines in India is almost entirely driven by companies manufacturing generic drugs. Almost all pharmaceutical companies operating in the country have expertise in developing generic drugs formulations of branded drugs developed by international companies so as to cater with underprivileged populations at a much cheaper price.
India has a huge disease burden and a large part of drugs sold in the country is meant for the treatment of several infectious and non-infectious diseases prevalent in the pediatric population. Pediatric drug are commonly used for diarrheal diseases such as cholera and viral gastroenteritis. Respiratory diseases including pneumonia and tuberculosis are other commonly treatable conditions for which drugs find extensive usage in the country.
Anti-infectives were the most frequently prescribed drug class by pediatricians, with over 80% of the prescriptions had some form of prescribed antibiotics. This is due to the wide scale prevalence of children being affected by respiratory diseases or some sort of microbial infections at regular basis.
India has emerged as leading vaccine producer in the world, in terms of doses of vaccines produced, and has about 12 major vaccine manufacturing facilities across the country. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). With over 25 million births every year, the domestic market for vaccines in India is huge. The country has been self sufficient in meeting the domestic needs, with private sector responsible for providing a large part of the supply needs.
Key Factors Considered in the Report
Pediatric Drug Development
Trends Pediatric Vaccine Market
Number Of Pediatrician Statistics
Pediatric Tuberculosis Drug Market
Drug Information, Dosage, Side Effects
Vaccines Market Growth India
Drug Pipeline Pediatric Drug
Vaccine Clinical Trials India
Pediatric Drug Market Industry Size
New Drug Launches India Pharma Sector
Pediatric Vaccine Serum Institute Of India
For more information on the market research report please refer to the below link:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Monday, January 23, 2017

Rising prevalence of chronic diseases & Inclusion of Several New Vaccines in National Immunization Programme to shape India Pediatric Drugs and Vaccines Market: Ken Research

“Launch of Anti TB drugs, introduction of IPV and several other vaccines in the national immunization programme to drive the India Pediatric Drugs and Vaccines Market”

India pediatric drugs and vaccine market has witnessed tremendous growth in the last five years largely due to high number of annual births recorded at around 25 million, launch of generic formulations of several pediatric drugs including flavored TB drugs, inclusion of several vaccines in the national immunization schedule of the country and inclining coverage of children vaccination under national immunization schedule.
Although a vast majority of the drugs sold in the country has been directed for the treatment of diseases as compared to management of the same. With rising prevalence of chronic diseases in the pediatric population of the country including diabetes and asthma, the market for drugs meant for management of diseases is deemed to incline at a faster pace in the near future.



Currently, procurement of pediatric drugs is almost entirely done through offline medium from hospital pharmacies, retail pharmacies, doctors or institutional health centers. Since the requirement of drugs is usually on an urgent basis, parents don’t prefer placing an order online and receive it a later date. However, online pharmacies have expanded at a steep pace in the last few years. Several players including the likes of Netmeds.com, 1mg, buydrug.in, Zigy, apollopharmacy.in and medidart.com have provided the much needed momentum to online retailing space. In the mid-long term, online sale of drugs is expected to witness healthy growth.
A large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form. This includes monovalent oral polio vaccine, BCG, measles, Hepatitis B and Hib. Some other commonly used monovalent vaccines include rotavirus vaccine and TT. Monovalent vaccines therefore comprised for the maximum market share as of FY’2016. However, with the expected inclusion of pentavalent in the immunization programme and launch of several multivalent vaccines in the country, the market share of multivalent vaccines is expected to incline.
The market for pediatrics vaccine in India has grown at a tremendous pace in the last five years. With the introduction of new vaccines in the national immunization programme, the market is expected to perform even better in the next five years. Indian government, as per the recommendation of WHO, has included Injectable Polio Vaccine (IPV) in its Universal Immunization Program. Further, the usage of pentavalent vaccine has been expanded to all the states and union territories. India has an ambition to eliminate measles, introduce rubella (as part of Measles Rubella vaccine), rotavirus and pneumococcal vaccines in 2017 and potentially Human Papilloma Virus (HPV) vaccine and Japanese Encephalitis vaccine at a later time, impacting the total India pediatric drugs and vaccines market in a positive manner.
With expected launch of rotavirus vaccine by Serum Institute of India in FY’2017 and quadrivalent influenza vaccine by Sanofi in FY’2018 amongst other vaccines, the pediatrics vaccine market is expected to grow at a high pace. .
The report titled “India Pediatric Drugs and Vaccines Market – Rise in prevalence of chronic diseases and inclusion of several new vaccines in national immunization programme to Shape Future Growth” provides detailed overview on the pediatric drugs and vaccines market in India. This report helps readers to identify the ongoing trends in the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report is useful for investors, pharmaceutical companies, contract manufacturers, startups, and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.
For more information about the publication, refer to the below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market
US Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar Wellness Market Outlook to 2020 - Rising Awareness about health & Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249